Coping Strategies for Financial Burdens in Families with Cardiovascular Diseases in Patients Attending in Selected Public and Private Hospitals inSanàa City 2023
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background Cardiovascular Diseases (CVD) are a group of disorders affecting the heart and blood vessels, such as ischemic heart disease and heart failure. Objectives The aim of this work was to determine the out-of-pocket expenditures and coping strategies employed by families of patients with CVD admitted to selected public and private hospitals in Yemen. Methods This cross- sectional descriptive study was carried out on 400 patients, admitted cardiovascular patients and selective outpatients came to treat in outpatient clinics at cardiovascular admission rooms and outpatient clinics in selected public and private hospitals. Data were collected through questionnaires covering socio-demographic details, medical history, lifestyle habits, cardiovascular disease characteristics, comorbidities, surgical history, and financial capacity for medical care. Results There was a significant relation between patients’ ability to afford medical expenses and type of hospital admitted to, age, place of residence, educational level, socio- economic factors except number of family members, diagnostic cardiac catheterization (P < 0.05). There was a significant relation between (open heart surgery and being late to take necessary health measures) and (duration of the disease, age, sex, and health habits) (P < 0.05). There was a significant relation between number of methods used to cover expenses and place of residence, job ad health insurance (P < 0.05). Conclusions Preventing CVD complications involved early detection, improved screening, and increased awareness of risk factors. Strengthened healthcare systems, public education, especially in rural areas and the implementation of comprehensive health insurance were key to improving outcomes and reducing the economic burden. Clinical Trial Number: Not Applicable